Veletri 0.5 (Epoprostenol sodium Vials) 0.5mg

Veletri 0.5 (epoprostenol sodium) is a prostaglandin vasodilator supplied as vials for intravenous use. This medication is commonly prescribed for pulmonary arterial hypertension to improve exercise capacity. Store at ambient temperature to maintain potency.

Strength

0.5mg

Pack Size

Storage

Ambient

Manufacturer / TM Owner

J&J

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Epoprostenol sodium is a vasodilator used to treat pulmonary arterial hypertension by relaxing blood vessels and improving blood flow. It may also be prescribed for other conditions where vasodilation is beneficial. Patients often ask, what is epoprostenol sodium used for in pulmonary conditions.

Side Effects

Veletri 0.5 helps dilate blood vessels, which can reduce strain on the heart and improve symptoms like shortness of breath. Some users report improved energy levels and reduced fatigue during daily activities. Individual responses may vary based on medical history.

Precautions & Warnings

Handle Veletri 0.5 vials with care to avoid contamination or damage. Keep the medication in its original packaging until ready to use. Store at room temperature and protect from light. Always follow healthcare provider instructions for administration and disposal.

Avoid Interactions

Epoprostenol sodium may interact with blood pressure medications, diuretics, or other vasodilators. Combining it with alcohol or certain supplements could enhance drowsiness or dizziness. Always inform your healthcare provider about all medications and supplements you are taking.

Frequently Asked Questions

Veletri 0.5 (epoprostenol sodium) is used to treat pulmonary arterial hypertension by improving blood flow and reducing heart strain.

Store Veletri 0.5 vials at room temperature, away from light and moisture. Do not freeze or refrigerate unless directed by a healthcare provider.

Consult your healthcare provider before combining Veletri 0.5 with other medications, as interactions may occur with blood pressure drugs or vasodilators.

Common effects may include flushing, headache, nausea, or dizziness. Report persistent or severe symptoms to your healthcare provider.

No, Veletri 0.5 requires a prescription from a licensed healthcare provider for safe and appropriate use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.